|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.11 CNY | -0.07% |
|
+2.43% | -26.21% |
| 06-10 | Chinese Drug Regulator Accepts Huadong Medicine's Application for Facial Filler's New Indication | MT |
| 05-21 | Huadong Medicine Co., Ltd Approves Cash Dividend for 2025, Payable on 10 June 2026 | CI |
| Market Cap | 51.05B 7.54B 6.52B 6B 5.62B 10.53B 717B 10.7B 70.9B 27.64B 349B 28.31B 27.71B 1,209B | P/E Ratio 2026 * |
13x | P/E Ratio 2027 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 46.38B 6.85B 5.92B 5.45B 5.11B 9.57B 651B 9.72B 64.4B 25.11B 317B 25.72B 25.17B 1,098B | EV / Sales 2026 * |
1x | EV / Sales 2027 * | 0.9x |
| Free-Float |
41.84% | Yield 2026 * |
2.6% | Yield 2027 * | 2.9% |
| 1 day | -0.07% | ||
| 1 week | +2.43% | ||
| Current month | +0.31% | ||
| 1 month | -13.26% | ||
| 3 months | -16.78% | ||
| 6 months | -29.77% | ||
| Current year | -26.21% |
| 1 week | 27.3 |  | 29.46 |
| 1 month | 27.3 | | 33.37 |
| Current year | 27.3 | | 40.49 |
| 1 year | 27.3 | | 47.36 |
| 3 years | 25.96 | | 47.36 |
| 5 years | 25.96 | | 51.91 |
| 10 years | 16.02 | | 53.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Lan Ma
DFI | Director of Finance/CFO | 55 | - |
Dong Zhou Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Li Hong Xie
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Wei Liu
BRD | Director/Board Member | 52 | 31/12/2002 |
Hang Fu
BRD | Director/Board Member | 62 | - |
Xin Hua Bai
CHM | Chairman | 60 | 31/12/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/02/20 | Sell | Chief Financial Officer | 6,000 | 0.0003% | ||
| 20/01/20 | Sell | 26,400 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | +2.43% | -35.41% | -27.86% | 7.54B | |
| -0.40% | +1.08% | +7.29% | +98.36% | 94.25B | |
| +1.22% | +8.82% | +39.45% | +156.77% | 52.43B | |
| -1.86% | -9.59% | -18.01% | +230.00% | 21.42B | |
| +0.62% | +0.49% | -11.87% | -26.06% | 8.13B | |
| +1.19% | -1.22% | -11.27% | -36.33% | 6.77B | |
| -2.80% | -2.46% | +9.63% | +20.45% | 6.49B | |
| +0.30% | +1.01% | -1.34% | +17.66% | 5.32B | |
| +1.27% | -3.62% | -12.11% | -15.86% | 3.53B | |
| -1.64% | -1.29% | +11.14% | +13.51% | 3.37B | |
| Average | -0.22% | +0.71% | -2.25% | +43.06% | 20.92B | |
| Weighted average by Cap. | -0.09% | +3.38% | +9.46% | +104.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 46.57B 6.88B 5.94B 5.48B 5.13B 9.61B 654B 9.76B 64.68B 25.22B 318B 25.83B 25.28B 1,103B | 49.11B 7.26B 6.27B 5.78B 5.41B 10.13B 690B 10.29B 68.2B 26.59B 336B 27.24B 26.66B 1,163B |
| Net income | 3.94B 582M 503M 463M 433M 812M 55.3B 825M 5.47B 2.13B 26.92B 2.18B 2.14B 93.21B | 4.39B 649M 560M 517M 483M 906M 61.68B 920M 6.1B 2.38B 30.02B 2.44B 2.38B 104B |
| Net Debt | -4.68B -691M -597M -550M -515M -965M -65.68B -980M -6.49B -2.53B -31.97B -2.59B -2.54B -111B | -7.02B -1.04B -896M -826M -773M -1.45B -98.61B -1.47B -9.75B -3.8B -48B -3.89B -3.81B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 29.11 ¥ | -0.07% | 15,457,920 |
| 11/06/26 | 29.13 ¥ | +1.78% | 17,002,920 |
| 10/06/26 | 28.62 ¥ | +2.58% | 20,235,420 |
| 09/06/26 | 27.90 ¥ | +0.76% | 8,932,591 |
| 08/06/26 | 27.69 ¥ | -2.57% | 13,705,238 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 000963 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition